Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
LogicBio Therapeutics, Inc. (LOGC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Beryl Capital Management LLC reports a 0% stake in LogicBio Therapeutics, Inc.
02/10/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/29/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
11/21/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/16/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/16/2022 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Fifth Amended and Restated Certificate of Incorporation of LogicBio Therapeutics, Inc",
"Amended and Restated Bylaws of LogicBio Therapeutics, Inc"
11/16/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/16/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/16/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/20/2022 8-K Quarterly results
10/20/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/18/2022 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/18/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/13/2022 SC 13G Beryl Capital Management LLC reports a 9.9% stake in LogicBio Therapeutics, Inc.
10/07/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
10/03/2022 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/03/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
10/03/2022 8-K Quarterly results
09/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Consulting Agreement by and between Cecilia Jones and LogicBio Therapeutics, Inc., effective as of September 23, 2022",
"Consulting Agreement by and between Cecilia Jones and LogicBio Therapeutics, Inc., effective as of September 23, 2022"
09/20/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
09/16/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
05/16/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 8-K Quarterly results
05/04/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy